Accessible Search Form           Advanced Search

John Barrett, M.D.

Publications


Principal Investigator thumbnail image

John Barrett
Senior Investigator

P: +1 301 402 4170
F: +1 301 480 2664
barrettj@nhlbi.nih.gov


Full Publications Listing

Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies.
Grube M, Rezvani K, Wiestner A, Fujiwara H, Sconocchia G, Melenhorst JJ, Hensel N, Marti GE, Kwak LW, Wilson W, Barrett JA.
Clin. Cancer Res. 2004 Feb 1;10(3):1047-56.
[Text Abstract on PubMed]

Nonmyeloablative allogeneic immunotherapy for solid tumors.
Childs RW, Barrett J.
Annu. Rev. Med. 2004;55:459-75.
[Text Abstract on PubMed]

Allogeneic stem cell transplantation for chronic myeloid leukemia.
Barrett J.
Semin. Hematol. 2003 Jan;40(1):59-71.
[Text Abstract on PubMed]

Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene.
Magnusson MK, Meade KE, Nakamura R, Barrett J, Dunbar CE.
Blood. 2002 Aug 1;100(3):1088-91.
[Text Abstract on PubMed]

Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation.
Hematti P, Sloand EM, Carvallo CA, Albert MR, Yee CL, Fuehrer MM, Blancato JK, Kearns WG, Barrett JA, Childs RW, Vogel JC, Dunbar CE.
Exp. Hematol. 2002 Aug;30(8):943-9.
[Text Abstract on PubMed]

A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome.
Maciejewski JP, Risitano AM, Sloand EM, Wisch L, Geller N, Barrett JA, Young NS, Ristiano AM.
Br. J. Haematol. 2002 Apr;117(1):119-26.
[Text Abstract on PubMed]

New directions in allogeneic stem cell transplantation.
Barrett J, Childs R.
Semin. Hematol. 2002 Jan;39(1):1-2.
[Text Abstract on PubMed]

The basis of the alloimmune response.
Barrett J.
Cytotherapy. 2002;4(5):419-22.
[Text Abstract on PubMed]

National Heart, Lung, and Blood Institute of the National Institutes of Health forum on immune reconstitution and cellular therapy following hematopoietic stem-cell transplantation.
Stroncek D, Harvath L, Barrett J.
Cytotherapy. 2002;4(5):415-8.
[Text Abstract on PubMed]

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study.
Walsh TJ, Goodman JL, Pappas P, Bekersky I, Buell DN, Roden M, Barrett J, Anaissie EJ.
Antimicrob. Agents Chemother. 2001 Dec;45(12):3487-96.
[Text Abstract on PubMed]

Non-myeloablative stem cell transplants.
Barrett J, Childs R.
Br. J. Haematol. 2000 Oct;111(1):6-17.
[Text Abstract on PubMed]

Myelodysplastic syndrome and aplastic anemia--diagnostic and conceptual uncertainties.
Barrett J.
Leuk. Res. 2000 Jul;24(7):595-6.
[Text Abstract on PubMed]

Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo.
Sloand EM, Kim S, Maciejewski JP, Van Rhee F, Chaudhuri A, Barrett J, Young NS.
Blood. 2000 Apr 1;95(7):2269-74.
[Text Abstract on PubMed]

Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect.
Childs R, Epperson D, Bahceci E, Clave E, Barrett J.
Br. J. Haematol. 1999 Nov;107(2):396-400.
[Text Abstract on PubMed]

Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
Cheson BD, Vena DA, Barrett J, Freidlin B.
J. Clin. Oncol. 1999 Aug;17(8):2454-60.
[Text Abstract on PubMed]

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.
Childs RW, Clave E, Tisdale J, Plante M, Hensel N, Barrett J.
J. Clin. Oncol. 1999 Jul;17(7):2044-9.
[Text Abstract on PubMed]

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.
Cheson BD, Sorensen JM, Vena DA, Montello MJ, Barrett JA, Damasio E, Tallman M, Annino L, Connors J, Coiffier B, Lauria F.
J. Clin. Oncol. 1998 Sep;16(9):3007-15.
[Text Abstract on PubMed]

Transfection of interleukin-12 cDNAs into tumor cells induces cytotoxic immune responses against native tumor: implications for tumor vaccination.
Hoshino T, Jiang YZ, Dunn D, Paul D, Qazilbash M, Cowan K, Wang J, Barrett J, Liu J.
Cancer Gene Ther. 1998 May-Jun;5(3):150-7.
[Text Abstract on PubMed]

The allogeneic CD4+ T-cell-mediated graft-versus-leukemia effect.
Jiang YZ, Barrett J.
Leuk. Lymphoma. 1997 Dec;28(1-2):33-42.
[Text Abstract on PubMed]

The graft-versus-leukemia effect.
Mavroudis D, Barrett J.
Curr. Opin. Hematol. 1996 Nov;3(6):423-9.
[Text Abstract on PubMed]

The graft-versus-leukemia effect.
Barrett J, Malkovska V.
Curr Opin Oncol. 1996 Mar;8(2):89-95.
[Text Abstract on PubMed]

Strategies to enhance the graft-versus-malignancy effect in allogeneic transplants.
Barrett JA.
Ann. N. Y. Acad. Sci. 1995 Dec 29;770:203-12.
[Text Abstract on PubMed]

Syngeneic bone marrow transplantation eliminates V beta 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis.
Burt RK, Burns W, Ruvolo P, Fischer A, Shiao C, Guimaraes A, Barrett J, Hess A.
J. Neurosci. Res. 1995 Jul 1;41(4):526-31.
[Text Abstract on PubMed]

The molecular basis of graft-versus-leukemia in CML.
Barrett J.
Bone Marrow Transplant. 1994;14 Suppl 3:S68-73.
[Text Abstract on PubMed]

Double minute chromosomes carrying the human multidrug resistance 1 and 2 genes are generated from the dimerization of submicroscopic circular DNAs in colchicine-selected KB carcinoma cells.
Schoenlein PV, Shen DW, Barrett JT, Pastan I, Gottesman MM.
Mol. Biol. Cell. 1992 May;3(5):507-20.
[Text Abstract on PubMed]

A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract.
Barrett JT, Orofiamma B, Khandekar JD, Carbone PP, Comis RL, Davis TE.
Cancer. 1989 Dec 15;64(12):2445-7.
[Text Abstract on PubMed]